Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-27 @ 10:00 AM
Study NCT ID:
NCT07022834
Status:
RECRUITING
Last Update Posted:
2025-06-15
First Post:
2025-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children
Sponsor:
West China Second University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2028-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-07
First Submit QC Date:
None
Study First Post Date:
2025-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-07
Last Update Post Date:
2025-06-15
Last Update Post Date Type:
ACTUAL